Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease

NCT01247090 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
End Stage Renal Disease

Interventions

DRUG: Vasopressin - Very Low Dose
DRUG: Vasopressin - Low Dose
DRUG: Placebo Comparator

Sponsor

Columbia University